Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$203.66 USD
+2.83 (1.41%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $203.79 +0.13 (0.06%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $0.50 | 34.00% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.20 per share. This reflects a negative earnings surprise of 85.00%. Look out for KRYS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of $0.50 per share, reflecting a year-over-year increase of 140%.
Earnings History
Price & Consensus
Zacks News for KRYS
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services